Recent Quotes

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is engaged in discovering, licensing, acquiring and developing drugs and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes biologics to prevent infectious diseases and small molecules and biologics to treat pain, psychiatric and addiction conditions. While the company is also developing a potential vaccine to protect against the novel coronavirus disease. Its main products are used for treating fibromyalgia, or FM, and posttraumatic stress disorder, or PTSD.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		-0.050		-0.070		-0.0200
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
TNXP	Tonix Pharmaceuticals	1.10	-0.02	-1.79%		363.6M

Tonix Pharmaceuticals Frequently Asked Questions

How do I buy Tonix Pharmaceuticals (TNXP) stock?

You can purchase shares of Tonix Pharmaceuticals (NASDAQ: TNXP) through any online brokerage.

View our list of the best stock brokerages.

Who are Tonix Pharmaceuticals's (TNXP) competitors?

Other companies in Tonix Pharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Fortress Biotech (NASDAQ:FBIO) and 89bio (NASDAQ:ETNB).

What is the target price for Tonix Pharmaceuticals (TNXP) stock?

The latest price target for Tonix Pharmaceuticals (NASDAQ: TNXP) was reported by Roth Capital on April 18, 2019. The analyst firm set a price target for 0.00 expecting TNXP to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Tonix Pharmaceuticals (TNXP)?

The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $1.1 last updated Thu Jun 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does Tonix Pharmaceuticals (TNXP) pay a dividend?

There are no upcoming dividends for Tonix Pharmaceuticals.

When is Tonix Pharmaceuticals (NASDAQ:TNXP) reporting earnings?

Tonix Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Tonix Pharmaceuticals (TNXP) going to split?

There is no upcoming split for Tonix Pharmaceuticals.

What sector and industry does Tonix Pharmaceuticals (TNXP) operate in?

Tonix Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.